Clinical Trials | November 24, 2025
Bayer’s experimental stroke drug could reshape secondary stroke prevention
Millions of stroke survivors across the world may soon have a new defense
Millions of stroke survivors across the world may soon have a new defense
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
The formulation is backed by over 80 clinical trials and 200 scientific publications
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
The 2025 edition of the EdelGive Hurun list recognizes 24 exceptional women leaders for their philanthropic impact across critical areas
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
The move is expected to be crucial during health crises
The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
Subscribe To Our Newsletter & Stay Updated
